These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4416065)

  • 21. Otospongiosis as a genetic disease. Early detection, medical management, and prevention.
    Causse JR; Causse JB
    Am J Otol; 1984 Jan; 5(3):211-23. PubMed ID: 6372501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical treatment of otosclerosis in elderly patients.
    Ayache D; Corre A; Van Prooyen S; Elbaz P
    Otolaryngol Head Neck Surg; 2003 Dec; 129(6):674-7. PubMed ID: 14663434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium fluoride: effectiveness of treatment for cochlear otosclerosis.
    Forquer BD; Linthicum FH; Bennett C
    Am J Otol; 1986 Mar; 7(2):121-5. PubMed ID: 3963156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Subcophosis and otosclerosis. Medical and surgical treatment].
    Causse JB; Causse JR; Lopez A; Gherini S; Griffin G; Michaux P; Cezard R; Parahy C; Chalard RG; Briand C
    Ann Otolaryngol Chir Cervicofac; 1990; 107(6):411-7. PubMed ID: 2256616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Enzymatic mechanism of otosclerosis. Action of NaF].
    Causse JR; Uriel J; Berges J; Bretlau P; Causse JB
    Ann Otolaryngol Chir Cervicofac; 1981; 98(6):269-97. PubMed ID: 6174065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [What may be expected from the therapy of otosclerosis using sodium fluoride?].
    Chládek V; Slaninová B
    Cesk Otolaryngol; 1977 Oct; 26(5):267-71. PubMed ID: 603948
    [No Abstract]   [Full Text] [Related]  

  • 27. Modification with NaF in disequilibrium of otospongiotic origin.
    Bretlau P; Causse JB; Causse J
    Adv Otorhinolaryngol; 1982; 28():73-9. PubMed ID: 7113821
    [No Abstract]   [Full Text] [Related]  

  • 28. Sensorineural deafness due to cochlear otospongiosis: pathogenesis, clinical diagnosis, and therapy.
    Shambaugh GE
    Otolaryngol Clin North Am; 1978 Feb; 11(1):135-54. PubMed ID: 662341
    [No Abstract]   [Full Text] [Related]  

  • 29. Medical treatment of otosclerosis: rationale for use of bisphosphonates.
    Brookler K
    Int Tinnitus J; 2008; 14(2):92-6. PubMed ID: 19205157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of drinking water fluoridation on hearing of patients with otosclerosis in a low fluoride area: a follow-up study.
    Vartiainen E; Karjalainen S; Nuutinen J; Suntioinen S; Pellinen P
    Am J Otol; 1994 Jul; 15(4):545-8. PubMed ID: 8588612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study of auditory sensitivity to low increase in intensity in patients with otosclerosis before and after stapes surgery].
    Petrova LN; Rozenblium AS
    Vestn Otorinolaringol; 1973; 35(1):73-6. PubMed ID: 4781553
    [No Abstract]   [Full Text] [Related]  

  • 32. Otospongiosis and sodium fluoride. A blind experimental and clinical evaluation of the effect of sodium fluoride treatment in patients with otospongiosis.
    Bretlau P; Causse J; Causse JB; Hansen HJ; Johnsen NJ; Salomon G
    Ann Otol Rhinol Laryngol; 1985; 94(2 Pt 1):103-7. PubMed ID: 3888030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of cochlear function in a patient with "far-advanced" otosclerosis.
    Keith RW; Kereiakes TJ; Willging JP; Devine J
    Am J Otol; 1992 Jul; 13(4):347-9. PubMed ID: 1415499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium fluoride and cochlear otospongiosis.
    Donaldson JA
    Arch Otolaryngol; 1977 Jun; 103(6):313. PubMed ID: 869760
    [No Abstract]   [Full Text] [Related]  

  • 35. Primary stapedotomy in children with otosclerosis: A prospective study of 41 consecutive cases.
    Vincent R; Wegner I; Vonck BM; Bittermann AJ; Kamalski DM; Grolman W
    Laryngoscope; 2016 Feb; 126(2):442-6. PubMed ID: 26016603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnosis and treatment of active cochlear otosclerosis.
    Shambaugh GE
    J Laryngol Otol; 1971 Apr; 85(4):301-14. PubMed ID: 5572823
    [No Abstract]   [Full Text] [Related]  

  • 37. Enzymology of otospongiosis and NaF therapy.
    Causse JR; Shambaugh GE; Causse B; Bretlau P
    Am J Otol; 1980 Apr; 1(4):206-14. PubMed ID: 6969991
    [No Abstract]   [Full Text] [Related]  

  • 38. Fluorides for otospongiosis and other osteoporotic states.
    Shambaugh GE
    Ann Otolaryngol Chir Cervicofac; 1973 Mar; 90(3):129-38. PubMed ID: 4717369
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of fluorine in otosclerosis (review of the foreign literature].
    Gukovich VA
    Zh Ushn Nos Gorl Bolezn; 1971; 31(1):117-21. PubMed ID: 4942008
    [No Abstract]   [Full Text] [Related]  

  • 40. Observations on the prosthesis in stapedectomy.
    Wardale A
    N Z Med J; 1971 Oct; 74(473):252-3. PubMed ID: 5289177
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.